Opus Genetics (IRD) Shares Outstanding (Weighted Average) (2010 - 2026)
Opus Genetics (IRD) reported Shares Outstanding (Weighted Average) of $86.9 million for Q1 2026, up 195.21% year-over-year from $29.4 million in Q1 2025, and up 279.36% on a QoQ basis from $22.9 million in Q4 2025.
Opus Genetics (IRD) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $86.9 million in Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 195.21% year-over-year to $86.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.9 million (up 195.21% YoY) and the FY2025 annual result came in at $22.9 million, down 14.26% from the prior year.
- Shares Outstanding (Weighted Average) climbed to $86.9 million in Q1 2026 per IRD's latest filing, from $22.9 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $86.9 million in Q1 2026 and bottomed at $63734.0 in Q2 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $21.1 million (2023), against an average of $22.8 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) slumped 99.53%; it then jumped 32786.38% in 2023.
- Tracing IRD's Shares Outstanding (Weighted Average) over 5 years: stood at $19.9 million in 2022, then climbed by 8.32% to $21.6 million in 2023, then rose by 23.74% to $26.7 million in 2024, then decreased by 14.26% to $22.9 million in 2025, then jumped by 279.36% to $86.9 million in 2026.
- Per Business Quant, the three latest IRD Shares Outstanding (Weighted Average) figures stand at $86.9 million (Q1 2026), $22.9 million (Q4 2025), and $56.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 86.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.89 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 56.10 Mn |
| Jun 30, 2025 | 29.43 Mn |
| Mar 31, 2025 | 29.43 Mn |
| Dec 31, 2024 | 26.72 Mn |
| Sep 30, 2024 | 26.15 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 21.59 Mn |
| Sep 30, 2023 | 21.12 Mn |
| Jun 30, 2023 | 20.96 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 19.93 Mn |
| Sep 30, 2022 | 20.50 Mn |
| Jun 30, 2022 | 63,734.00 |
| Mar 31, 2022 | 1.54 Mn |
| Dec 31, 2021 | 14.85 Mn |
| Sep 30, 2021 | 1.54 Mn |
| Jun 30, 2021 | 13.61 Mn |
| Mar 31, 2021 | 66,538.00 |
| Dec 31, 2020 | 4.66 Mn |
| Sep 30, 2020 | 925,732.00 |
| Jun 30, 2020 | 3.65 Mn |
| Mar 31, 2020 | 1.92 Mn |
| Dec 31, 2019 | 2.84 Mn |
| Sep 30, 2019 | 4.02 Mn |
| Jun 30, 2019 | 1.92 Mn |
| Mar 31, 2019 | 1.92 Mn |
| Dec 31, 2018 | 1.07 Mn |
| Sep 30, 2018 | 6.90 Mn |
| Jun 30, 2018 | 7.10 Mn |
| Mar 31, 2018 | 7.10 Mn |
| Dec 31, 2017 | 7.10 Mn |
| Sep 30, 2017 | 5.29 Mn |
| Jun 30, 2017 | 5.29 Mn |
| Mar 31, 2017 | 23.85 Mn |
| Dec 31, 2016 | 5.45 Mn |
| Sep 30, 2016 | 5.45 Mn |
| Jun 30, 2016 | 3.90 Mn |
| Mar 31, 2016 | 202.59 Mn |
| Dec 31, 2015 | 2.65 Mn |
| Sep 30, 2015 | 180.70 Mn |
| Jun 30, 2015 | 179.85 Mn |
| Mar 31, 2015 | 179.10 Mn |
| Dec 31, 2014 | 13.21 Mn |
| Sep 30, 2014 | 178.22 Mn |
| Jun 30, 2014 | 13.98 Mn |
| Mar 31, 2014 | 18.92 Mn |
| Dec 31, 2013 | 24.97 Mn |
| Sep 30, 2013 | 130.47 Mn |
| Jun 30, 2013 | 21.60 Mn |
| Mar 31, 2013 | 21.66 Mn |
| Dec 31, 2012 | 21.66 Mn |
| Sep 30, 2012 | 95.35 Mn |
| Jun 30, 2012 | 95.35 Mn |
| Mar 31, 2012 | 8.68 Mn |
| Dec 31, 2011 | 8.68 Mn |
| Sep 30, 2011 | 8.68 Mn |
| Jun 30, 2011 | 90.77 Mn |
| Mar 31, 2011 | 86.25 Mn |
| Dec 31, 2010 | 5.62 Mn |
| Sep 30, 2010 | 76.93 Mn |
| Jun 30, 2010 | 74.25 Mn |